{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:00:36Z","timestamp":1792522836321,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T00:00:00Z","timestamp":1442016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00259-015-3183-6","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T01:28:49Z","timestamp":1442021329000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [18F]-fluoroethyltyrosine (FET) PET\/MRI: feasibility, agreement and initial experience"],"prefix":"10.1007","volume":"43","author":[{"given":"Otto M.","family":"Henriksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke A.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Muhic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik B. W.","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans S.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,12]]},"reference":[{"key":"3183_CR1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1227\/01.NEU.0000171642.49553.B0","volume":"57","author":"W Rachinger","year":"2005","unstructured":"Rachinger W, Goetz C, Popperl G, Gildehaus FJ, Kreth FW, Holtmannspotter M, et al. Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery. 2005;57:505\u201311.","journal-title":"Neurosurgery"},{"key":"3183_CR2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2009.92","volume":"6","author":"AD Waldman","year":"2009","unstructured":"Waldman AD, Jackson A, Price SJ, Clark CA, Booth TC, Auer DP, et al. Quantitative imaging biomarkers in neuro-oncology. Nat Rev Clin Oncol. 2009;6:445\u201354.","journal-title":"Nat Rev Clin Oncol"},{"key":"3183_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jocn.2009.05.009","volume":"17","author":"EW Lau","year":"2010","unstructured":"Lau EW, Drummond KJ, Ware RE, Drummond E, Hogg A, Ryan G, et al. Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour. J Clin Neurosci. 2010;17:43\u20139.","journal-title":"J Clin Neurosci"},{"key":"3183_CR4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.nucmedbio.2009.05.005","volume":"36","author":"D Pauleit","year":"2009","unstructured":"Pauleit D, Stoffels G, Bachofner A, Floeth FW, Sabel M, Herzog H, et al. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors. Nucl Med Biol. 2009;36:779\u201387.","journal-title":"Nucl Med Biol"},{"key":"3183_CR5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awh399","volume":"128","author":"D Pauleit","year":"2005","unstructured":"Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, Muller HW, et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain. 2005;128:678\u201387.","journal-title":"Brain"},{"key":"3183_CR6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2967\/jnumed.106.037895","volume":"48","author":"FW Floeth","year":"2007","unstructured":"Floeth FW, Pauleit D, Sabel M, Stoffels G, Reifenberger G, Riemenschneider MJ, et al. Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma. J Nucl Med. 2007;48:519\u201327.","journal-title":"J Nucl Med"},{"key":"3183_CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/neuonc\/nos300","volume":"15","author":"M Hutterer","year":"2013","unstructured":"Hutterer M, Nowosielski M, Putzer D, Jansen NL, Seiz M, Schocke M, et al. [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. Neuro Oncol. 2013;15:341\u201351.","journal-title":"Neuro Oncol"},{"key":"3183_CR8","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00259-004-1590-1","volume":"31","author":"G Popperl","year":"2004","unstructured":"Popperl G, Gotz C, Rachinger W, Gildehaus FJ, Tonn JC, Tatsch K. Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging. 2004;31:1464\u201370.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3183_CR9","first-page":"1989","volume":"24","author":"M Law","year":"2003","unstructured":"Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003;24:1989\u201398.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3183_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00234-012-1127-4","volume":"55","author":"VA Larsen","year":"2013","unstructured":"Larsen VA, Simonsen HJ, Law I, Larsson HB, Hansen AE. Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis. Neuroradiology. 2013;55:361\u20139.","journal-title":"Neuroradiology"},{"key":"3183_CR11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jmri.24648","volume":"41","author":"MS Shiroishi","year":"2015","unstructured":"Shiroishi MS, Castellazzi G, Boxerman JL, D'Amore F, Essig M, Nguyen TB, et al. Principles of T2*-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging. J Magn Reson Imaging. 2015;41:296\u2013313.","journal-title":"J Magn Reson Imaging"},{"key":"3183_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neurad.2009.04.005","volume":"37","author":"V Dandois","year":"2010","unstructured":"Dandois V, Rommel D, Renard L, Jamart J, Cosnard G. Substitution of 11C-methionine PET by perfusion MRI during the follow-up of treated high-grade gliomas: preliminary results in clinical practice. J Neuroradiol. 2010;37:89\u201397.","journal-title":"J Neuroradiol"},{"key":"3183_CR13","first-page":"455","volume":"28","author":"N Sadeghi","year":"2007","unstructured":"Sadeghi N, Salmon I, Decaestecker C, Levivier M, Metens T, Wikler D, et al. Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. AJNR Am J Neuroradiol. 2007;28:455\u201361.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3183_CR14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/jmri.20757","volume":"24","author":"N Sadeghi","year":"2006","unstructured":"Sadeghi N, Salmon I, Tang BN, Denolin V, Levivier M, Wikler D, et al. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results. J Magn Reson Imaging. 2006;24:989\u201394.","journal-title":"J Magn Reson Imaging"},{"key":"3183_CR15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2967\/jnumed.113.129007","volume":"55","author":"CP Filss","year":"2014","unstructured":"Filss CP, Galldiks N, Stoffels G, Sabel M, Wittsack HJ, Turowski B, et al. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET\/MR imaging hybrid study in patients with brain tumors. J Nucl Med. 2014;55:540\u20135.","journal-title":"J Nucl Med"},{"key":"3183_CR16","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/0284185114550020","volume":"56","author":"A Tietze","year":"2015","unstructured":"Tietze A, Boldsen JK, Mouridsen K, Ribe L, Dyve S, Cortnum S, et al. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging. Acta Radiol. 2015;56:1135\u201344.","journal-title":"Acta Radiol"},{"key":"3183_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11060-013-1178-3","volume":"114","author":"SG Berntsson","year":"2013","unstructured":"Berntsson SG, Falk A, Savitcheva I, Godau A, Zetterling M, Hesselager G, et al. Perfusion and diffusion MRI combined with (11)C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas. J Neurooncol. 2013;114:241\u20139.","journal-title":"J Neurooncol"},{"key":"3183_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/153303461000900102","volume":"9","author":"HF Wehrl","year":"2010","unstructured":"Wehrl HF, Sauter AW, Judenhofer MS, Pichler BJ. Combined PET\/MR imaging \u2013 technology and applications. Technol Cancer Res Treat. 2010;9:5\u201320.","journal-title":"Technol Cancer Res Treat"},{"key":"3183_CR19","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.2967\/jnumed.111.092726","volume":"52","author":"G Delso","year":"2011","unstructured":"Delso G, Furst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET\/MR scanner. J Nucl Med. 2011;52:1914\u201322.","journal-title":"J Nucl Med"},{"key":"3183_CR20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuroimage.2013.08.042","volume":"84","author":"FL Andersen","year":"2014","unstructured":"Andersen FL, Ladefoged CN, Beyer T, Keller SH, Hansen AE, Hojgaard L, et al. Combined PET\/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone. Neuroimage. 2014;84:206\u201316.","journal-title":"Neuroimage"},{"key":"3183_CR21","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jcbfm.2011.52","volume":"31","author":"A Bjornerud","year":"2011","unstructured":"Bjornerud A, Sorensen AG, Mouridsen K, Emblem KE. T1- and T2*-dominant extravasation correction in DSC-MRI: part I \u2013 theoretical considerations and implications for assessment of tumor hemodynamic properties. J Cereb Blood Flow Metab. 2011;31:2041\u201353.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3183_CR22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3174\/ajnr.A1465","volume":"30","author":"S Bisdas","year":"2009","unstructured":"Bisdas S, Kirkpatrick M, Giglio P, Welsh C, Spampinato MV, Rumboldt Z. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease? AJNR Am J Neuroradiol. 2009;30:681\u20138.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3183_CR23","first-page":"859","volume":"27","author":"JL Boxerman","year":"2006","unstructured":"Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol. 2006;27:859\u201367.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3183_CR24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrclinonc.2014.223","volume":"12","author":"DA Reardon","year":"2015","unstructured":"Reardon DA, Wen PY. Glioma in 2014: unravelling tumour heterogeneity \u2013 implications for therapy. Nat Rev Clin Oncol. 2015;12:69\u201370.","journal-title":"Nat Rev Clin Oncol"},{"key":"3183_CR25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/neuonc\/nou035","volume":"16","author":"A Vartanian","year":"2014","unstructured":"Vartanian A, Singh SK, Agnihotri S, Jalali S, Burrell K, Aldape KD, et al. GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity. Neuro Oncol. 2014;16:1167\u201375.","journal-title":"Neuro Oncol"},{"key":"3183_CR26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.drudis.2014.10.016","volume":"20","author":"S Puttick","year":"2015","unstructured":"Puttick S, Bell C, Dowson N, Rose S, Fay M. PET, MRI, and simultaneous PET\/MRI in the development of diagnostic and therapeutic strategies for glioma. Drug Discov Today. 2015;20:306\u201317.","journal-title":"Drug Discov Today"},{"key":"3183_CR27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/RLI.0b013e31827188d6","volume":"48","author":"S Bisdas","year":"2013","unstructured":"Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, et al. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Invest Radiol. 2013;48:295\u2013301.","journal-title":"Invest Radiol"},{"key":"3183_CR28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s00259-013-2652-z","volume":"41","author":"JC Dickson","year":"2014","unstructured":"Dickson JC, O'Meara C, Barnes A. A comparison of CT- and MR-based attenuation correction in neurological PET. Eur J Nucl Med Mol Imaging. 2014;41:1176\u201389.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3183_CR29","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/neuonc\/nos259","volume":"14","author":"NL Jansen","year":"2012","unstructured":"Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, et al. Prediction of oligodendroglial histology and LOH 1p\/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas. Neuro Oncol. 2012;14:1473\u201380.","journal-title":"Neuro Oncol"},{"key":"3183_CR30","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ejrad.2011.04.009","volume":"81","author":"T Saito","year":"2012","unstructured":"Saito T, Yamasaki F, Kajiwara Y, Abe N, Akiyama Y, Kakuda T, et al. Role of perfusion-weighted imaging at 3T in the histopathological differentiation between astrocytic and oligodendroglial tumors. Eur J Radiol. 2012;81:1863\u20139.","journal-title":"Eur J Radiol"},{"key":"3183_CR31","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.ejrad.2015.02.025","volume":"84","author":"A Stadlbauer","year":"2015","unstructured":"Stadlbauer A, Pichler P, Karl M, Brandner S, Lerch C, Renner B, et al. Quantification of serial changes in cerebral blood volume and metabolism in patients with recurrent glioblastoma undergoing antiangiogenic therapy. Eur J Radiol. 2015;84:1128\u201336.","journal-title":"Eur J Radiol"},{"key":"3183_CR32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00259-012-2251-4","volume":"40","author":"N Galldiks","year":"2013","unstructured":"Galldiks N, Rapp M, Stoffels G, Fink GR, Shah NJ, Coenen HH, et al. Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI. Eur J Nucl Med Mol Imaging. 2013;40:22\u201333.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3183_CR33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11060-014-1586-z","volume":"120","author":"MK Rau","year":"2014","unstructured":"Rau MK, Braun C, Skardelly M, Schittenhelm J, Paulsen F, Bender B, et al. Prognostic value of blood flow estimated by arterial spin labeling and dynamic susceptibility contrast-enhanced MR imaging in high-grade gliomas. J Neurooncol. 2014;120:557\u201366.","journal-title":"J Neurooncol"},{"key":"3183_CR34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1148\/radiol.2472070898","volume":"247","author":"M Law","year":"2008","unstructured":"Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology. 2008;247:490\u20138.","journal-title":"Radiology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3183-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-015-3183-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3183-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:06:28Z","timestamp":1558699588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-015-3183-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["3183"],"URL":"https:\/\/doi.org\/10.1007\/s00259-015-3183-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,12]]}}}